| Not Yet Recruiting | Precision Supplemental Imaging in Women With Dense Breasts NCT07277738 | Washington University School of Medicine | N/A |
| Recruiting | A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer ( NCT07067138 | National Cancer Institute (NCI) | N/A |
| Recruiting | Breast Re-irradiation After Second Ipsilateral Lumpectomy NCT06867484 | Youssef Zeidan | N/A |
| Recruiting | Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728 | Psyence Australia Pty Ltd | Phase 2 |
| Recruiting | ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and NCT06981208 | Washington University School of Medicine | N/A |
| Recruiting | DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY NCT06749210 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Not Yet Recruiting | Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Vali NCT06711939 | Mitera Hospital | — |
| Recruiting | NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positiv NCT05837455 | Washington University School of Medicine | Phase 2 |
| Recruiting | A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer NCT06471673 | BriaCell Therapeutics Corporation | Phase 1 / Phase 2 |
| Recruiting | COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients NCT05972343 | Washington University School of Medicine | — |
| Completed | Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial) NCT05716542 | Washington University School of Medicine | N/A |
| Withdrawn | Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC NCT05191004 | Nuvation Bio Inc. | Phase 1 / Phase 2 |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Completed | Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting NCT06595901 | Washington University School of Medicine | — |
| Recruiting | Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negativ NCT04968964 | Washington University School of Medicine | N/A |
| Terminated | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NCT04541225 | Nuvation Bio Inc. | Phase 1 |
| Terminated | Real-time Intraoperative Breast Cancer Visualization for Margin Assessment NCT02807597 | Samuel Achilefu | Phase 1 / Phase 2 |
| Recruiting | Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low NCT02476786 | Washington University School of Medicine | Phase 2 |
| Completed | Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment NCT02891681 | Washington University School of Medicine | N/A |
| Terminated | Pre- Versus Postoperative Accelerated Partial Breast Irradiation NCT02913729 | The Netherlands Cancer Institute | N/A |
| Terminated | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914 | Washington University School of Medicine | Phase 2 |
| Terminated | Shave Margins in Breast Conservation Therapy NCT02462200 | Washington University School of Medicine | Phase 2 |
| Completed | Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy NCT02595372 | Kathy Miller | Phase 2 |
| Completed | Bright Light on Fatigue in Women Being Treated for Breast Cancer NCT02658708 | Washington University School of Medicine | Phase 1 |
| Completed | Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects NCT02302196 | Kaiser Permanente | — |
| Completed | CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) NCT02580448 | Innocrin Pharmaceutical | Phase 1 / Phase 2 |
| Withdrawn | Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers NCT02396433 | The University of Texas Health Science Center at San Antonio | Phase 1 / Phase 2 |
| Completed | Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma NCT02316795 | Washington University School of Medicine | EARLY_Phase 1 |
| Completed | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabin NCT01881230 | Celgene | Phase 2 / Phase 3 |
| Active Not Recruiting | Proton Radiation for Stage II/III Breast Cancer NCT01758445 | Proton Collaborative Group | Phase 2 |
| Recruiting | Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer NCT01766297 | Proton Collaborative Group | Phase 2 |
| Terminated | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer NCT01498588 | Emory University | Phase 2 |
| Terminated | A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer NCT01272141 | Emory University | Phase 2 |
| Completed | Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer NCT01118624 | Acrotech Biopharma Inc. | Phase 2 |
| Completed | Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer NCT01271738 | Emory University | N/A |
| Terminated | Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores NCT00832338 | Emory University | Phase 2 |
| Terminated | Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breas NCT00817362 | Infinity Pharmaceuticals, Inc. | Phase 2 |
| Terminated | Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocri NCT00661531 | Georgetown University | Phase 2 |
| Completed | Multipeptide Vaccine for Advanced Breast Cancer NCT00573495 | University of Pennsylvania | Phase 1 |
| Completed | Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer NCT00530868 | University of Alabama at Birmingham | Phase 2 |
| Active Not Recruiting | Axillary Reverse Mapping NCT00572481 | University of Arkansas | Phase 2 |
| Completed | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer NCT00217815 | NeuTec Pharma | Phase 1 / Phase 2 |
| Terminated | Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer NCT00128362 | Tata Memorial Hospital | Phase 2 |
| Completed | Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation NCT00193778 | Tata Memorial Hospital | N/A |
| Completed | Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation NCT00571987 | University of Arkansas | Phase 1 / Phase 2 |
| Completed | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease NCT00191373 | Eli Lilly and Company | Phase 2 |
| Completed | A Phase III Trial For Patients With Metastatic Breast Cancer NCT00191152 | Eli Lilly and Company | Phase 3 |